Evidence for ebola virus superantigen activity

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 4041-4042

  Leroy, Eric M ^a   Becquart, Pierre ^a   Wauquier, Nadia ^b   Baize, Sylvain ^c  

^a CNRS   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c Institut Pasteur   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN BINDING; APOPTOSIS; B LYMPHOCYTE; DOWN REGULATION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; GENE EXPRESSION; HUMAN; IMMUNE DEFICIENCY; LETTER; NONHUMAN; PRIORITY JOURNAL; SHOCK; T LYMPHOCYTE; UPREGULATION; VIRUS VIRULENCE; ZAIRE EBOLA VIRUS;

ANTIGENS, VIRAL; APOPTOSIS; B-LYMPHOCYTES; EBOLAVIRUS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; SUPERANTIGENS; T-LYMPHOCYTES; VIRULENCE FACTORS;

EBOLA VIRUS;

EID: 79952849783     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00181-11     Document Type: Letter

References (14)

1. Baize, S., et al. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5:1-5.
2. Bermejo, M., et al. 2006. Ebola outbreak killed 5000 gorillas. Science 314: 1564. (Pubitemid 44907142)
3. Bradfute, S. B., K. L. Warfield, and S. Bavari. 2008. Functional CD8+ T cell responses in lethal Ebola virus infection. J. Immunol. 180:4058-4066.
4. Fraser, J. D., and T. Proft. 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225:226-243.
5. Geisbert, T. W., and P. B. Jahrling. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110-S121.
6. Hensley, L., H. A. Young, P. B. Jahrling, and T. W. Geisbert. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80:169-179.
7. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
8. Lafon, M., et al. 1992. Evidence for a viral superantigen in humans. Nature 358:507-510.
9. Leroy, E. M., et al. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210-2215. (Pubitemid 30394329)
10. Leroy, E. M., et al. 2004. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303:387-390. (Pubitemid 38095781)
11. Sanchez, A., T. W. Geisbert, and H. Feldmann. 2007. Filoviridae: Marburg and Ebola viruses, p. 1409-1448. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Sutkowski, N., et al. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971-980.
13. Walsh, P. D., et al. 2003. Catastrophic ape decline in western equatorial Africa. Nature 422:611-614. (Pubitemid 36460413)
14. Wauquier, N., P. Becquart, C. Padilla, S. Baize, and E. M. Leroy. 2010. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and massive lymphocyte apoptosis. PLoS Neg. Trop. Dis. 4:e837.